Erratum: Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma (Cell (2018) 175(4) (998–1013.e20), (S0092867418313941) (10.1016/j.cell.2018.10.038))

Moshe Sade-Feldman, Keren Yizhak, Stacey L. Bjorgaard, John P. Ray, Carl G. de Boer, Russell W. Jenkins, David J. Lieb, Jonathan H. Chen, Dennie T. Frederick, Michal Barzily-Rokni, Samuel S. Freeman, Alexandre Reuben, Paul J. Hoover, Alexandra Chloé Villani, Elena Ivanova, Andrew Portell, Patrick H. Lizotte, Amir R. Aref, Jean Pierre Eliane, Marc R. HammondHans Vitzthum, Shauna M. Blackmon, Bo Li, Vancheswaran Gopalakrishnan, Sangeetha M. Reddy, Zachary A. Cooper, Cloud P. Paweletz, David A. Barbie, Anat Stemmer-Rachamimov, Keith T. Flaherty, Jennifer A. Wargo, Genevieve M. Boland, Ryan J. Sullivan, Gad Getz, Nir Hacohen

Research output: Contribution to journalComment/debate

8 Scopus citations


(Cell 175, 998–1013.e1–e20; November 1, 2018) In the originally published version of this article, the text associated with the vertical axis in Figure 6E mistakenly referred to the CD39TIM3/ CD39+TIM3+ ratio, but the values correspond to the inverse ratio, i.e., CD39+TIM3+/CD39TIM3. The corrected Figure 6E is shown here, and this error has now been corrected in the article online. The authors apologize for any confusion this error may have caused. [Figure presented]

Original languageEnglish (US)
Number of pages1
Issue number1-2
Publication statusPublished - Jan 10 2019
Externally publishedYes


ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this